Steven Cohen’s Eupraxia Pharmaceuticals EPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding EPRX
Steven Cohen's EPRX Position: Q3 2026 in Review
Steven Cohen sold out of Eupraxia Pharmaceuticals (EPRX) in Q3 2026, closing a stake of 730,284 shares — an estimated $4.83M sold.
Steven Cohen first reported a position in EPRX in Q4 2025 and held it in 3 quarters. The position peaked at $7.01M in Q1 2026. 70 funds tracked by Wall St. Rank hold EPRX as of Q3 2026.
- Steven Cohen reported no remaining Eupraxia Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Steven Cohen sold 730,284 Eupraxia Pharmaceuticals shares in Q3 2026, an estimated $4.83M.
- Steven Cohen first reported a position in Eupraxia Pharmaceuticals in Q4 2025 and held it in 3 quarters.
- Steven Cohen's Eupraxia Pharmaceuticals position peaked at $7.01M in Q1 2026.
- 70 funds tracked by Wall St. Rank held Eupraxia Pharmaceuticals as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.